Literature DB >> 22146554

Serum xylosyltransferase 1 level increases during early posttraumatic osteoarthritis in mice with high bone forming potential.

Sarah Y McCoy1, Kerry A Falgowski, Padma P Srinivasan, William R Thompson, Erica M Selva, Catherine B Kirn-Safran.   

Abstract

Increased proteoglycan (PG) synthesis is essential for the stimulation of cartilage repair processes that take place during the reversible phase of osteoarthritis (OA). In articular cartilage, xylosyltransferase 1 (Xylt1) is the key enzyme that initiates glycosaminoglycan (GAG) chain synthesis by transferring the first sugar residue to the PG core protein. Biological activity of PGs is closely linked to GAG biosynthesis since their polyanionic nature directly contributes to the proper hydration and elastic properties of the cartilage tissue present at the articular interface. The aim of this study was to investigate whether variations in the level of Xylt1 present in serum can be used to predict OA disease progression. The influence of bone forming activity on the systemic release of this enzyme was addressed by experimentally-inducing OA in mice of two different genetic backgrounds that were previously characterized for their distinct bone metabolism: C57BL/6J (B6, high bone remodelers) or C3H/HeJ (C3H, high bone formers). Serum was collected after medial meniscectomy or sham surgeries in young adult mice of these two strains over a period of 3.5months at which point knee histopathology was assessed. A significant increase in serum Xylt1 levels observed shortly after meniscectomy positively correlated with severe cartilage damage evaluated by histological assessment at later time points in mice of the C3H background. In contrast, no temporal regulation of Xylt1 level was found between meniscectomies and control surgeries in B6 mice, which developed OA at a slower rate. Additionally, longitudinal evaluation of the serum levels of other markers of cartilage/bone metabolism (C1,2C, osteocalcin) did not reveal any association with late knee damages. Our results strongly support the idea that serum Xylt1 has a clinical value for monitoring risk of OA progression in young adults with high bone forming potential. Ultimately, the understanding of posttraumatic mechanisms regulating PG synthesis and their modification by GAG will be essential so that interventions that stimulate cartilage regrowth can be undertaken prior to irreversible destruction of the joint tissue. This article is part of a Special Issue entitled "Osteoarthritis".
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22146554      PMCID: PMC3319505          DOI: 10.1016/j.bone.2011.11.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  39 in total

1.  Mechanotransduction in bone: genetic effects on mechanosensitivity in mice.

Authors:  A G Robling; C H Turner
Journal:  Bone       Date:  2002-11       Impact factor: 4.398

2.  Lower bone cellular activities in male and female mature C3H/HeJ mice are associated with higher bone mass and different pyridinium crosslink profiles compared to C57BL/6J mice.

Authors:  Daniel Amblard; Marie-Hélène Lafage-Proust; Annette Chamson; Aline Rattner; Philippe Collet; Christian Alexandre; Laurence Vico
Journal:  J Bone Miner Metab       Date:  2003       Impact factor: 2.626

3.  Mutational and functional analyses of xylosyltransferases and their implication in osteoarthritis.

Authors:  S Schön; G Huep; C Prante; S Müller; R Christ; F-W Hagena; J Kuhn; K Kleesiek; C Götting
Journal:  Osteoarthritis Cartilage       Date:  2005-12-22       Impact factor: 6.576

4.  Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

Authors:  Patrick Garnero; Xavier Ayral; Jean-Charles Rousseau; S Christgau; Linda J Sandell; Maxime Dougados; Pierre D Delmas
Journal:  Arthritis Rheum       Date:  2002-10

5.  Osteoarthritis cartilage histopathology: grading and staging.

Authors:  K P H Pritzker; S Gay; S A Jimenez; K Ostergaard; J-P Pelletier; P A Revell; D Salter; W B van den Berg
Journal:  Osteoarthritis Cartilage       Date:  2005-10-19       Impact factor: 6.576

6.  Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.

Authors:  R C Billinghurst; W Wu; M Ionescu; A Reiner; L Dahlberg; J Chen; H van Wart; A R Poole
Journal:  Arthritis Rheum       Date:  2000-03

7.  Tail suspension induces bone loss in skeletally mature mice in the C57BL/6J strain but not in the C3H/HeJ strain.

Authors:  Daniel Amblard; Marie-Hélène Lafage-Proust; Andres Laib; Thierry Thomas; Peter Rüegsegger; Christian Alexandre; Laurence Vico
Journal:  J Bone Miner Res       Date:  2003-03       Impact factor: 6.741

8.  Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.

Authors:  Kristen M Clements; Joanne S Price; Mark G Chambers; Denise M Visco; A Robin Poole; Roger M Mason
Journal:  Arthritis Rheum       Date:  2003-12

9.  Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis.

Authors:  O Bruyere; C Dardenne; E Lejeune; B Zegels; A Pahaut; F Richy; L Seidel; O Ethgen; Y Henrotin; J-Y Reginster
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

Review 10.  Aggrecanases and cartilage matrix degradation.

Authors:  Hideaki Nagase; Masahide Kashiwagi
Journal:  Arthritis Res Ther       Date:  2003-02-14       Impact factor: 5.156

View more
  6 in total

1.  First Characterization of Human Dermal Fibroblasts Showing a Decreased Xylosyltransferase-I Expression Induced by the CRISPR/Cas9 System.

Authors:  Bastian Fischer; Vanessa Schmidt; Thanh-Diep Ly; Anika Kleine; Cornelius Knabbe; Isabel Faust-Hinse
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

2.  Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.

Authors:  Joachim Kuhn; Christian Götting; Brendan J Beahm; Carolyn R Bertozzi; Isabel Faust; Patricia Kuzaj; Cornelius Knabbe; Doris Hendig
Journal:  Biochem Biophys Res Commun       Date:  2015-03-03       Impact factor: 3.575

Review 3.  Pros and cons of mouse models for studying osteoarthritis.

Authors:  Santul Bapat; Daniel Hubbard; Akul Munjal; Monte Hunter; Sadanand Fulzele
Journal:  Clin Transl Med       Date:  2018-11-21

4.  Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation.

Authors:  Matthew Prideaux; Christian S Wright; Megan L Noonan; Xin Yi; Erica L Clinkenbeard; Elsa Mevel; Jonathan A Wheeler; Sharon Byers; Asiri R Wijenayaka; Stan Gronthos; Uma Sankar; Kenneth E White; Gerald J Atkins; William R Thompson
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

Review 5.  Animal models of osteoarthritis: classification, update, and measurement of outcomes.

Authors:  Emmanuel L Kuyinu; Ganesh Narayanan; Lakshmi S Nair; Cato T Laurencin
Journal:  J Orthop Surg Res       Date:  2016-02-02       Impact factor: 2.359

6.  Integration of Gene Expression Profile Data to Screen and Verify Hub Genes Involved in Osteoarthritis.

Authors:  Zhaoyan Li; Qingyu Wang; Gaoyang Chen; Xin Li; Qiwei Yang; Zhenwu Du; Ming Ren; Yang Song; Guizhen Zhang
Journal:  Biomed Res Int       Date:  2018-08-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.